Sign in Subscribe
Cancer research

Ovarian Cancer Research Uncovers Novel Mechanisms of Immunosuppression

Strategic Insights

— 1 min read

A recent study published in the Journal of Experimental & Clinical Cancer Research has shed light on the mechanisms of immunosuppression in ovarian cancer, a type of cancer that affects women's reproductive organs. Researchers from Shanghai First Maternity and Infant Hospital in China have discovered a novel feedback loop involving Serum Amyloid A1 (SAA1) and interleukin-1 beta (IL-1β) that promotes immunosuppression and progression in ovarian cancer.

Key Takeaways:

  • The study found that myeloid-derived suppressor cells (MDSCs) play a crucial role in shaping the tumor microenvironment and contributing to resistance against immunotherapy in ovarian cancer.
  • The researchers identified a positive feedback loop involving SAA1 and IL-1β that promotes cancer cell proliferation, migration, and invasion, and recruits MDSCs to the tumor site.
  • High levels of SAA1, IL-1β, and CD33+ MDSCs in ovarian cancer patients correlated with poor survival.
  • The study suggests that SAA1 and IL-1β may serve as potential biomarkers and therapeutic targets for ovarian cancer.

Statistics:

  • 44% of ovarian cancer patients' tumor tissues showed high levels of SAA1 expression.
  • IL-1β levels were significantly elevated in ovarian cancer cells co-cultured with MDSCs.
  • The positive feedback loop between SAA1 and IL-1β was confirmed in both tumor samples and cell lines.
  • In vivo experiments showed that SAA1 promoted tumor progression and ascites formation in mouse models.

Sources:

  • Tumor cells promote immunosuppression in ovarian cancer via a positive feedback loop with MDSCs through the SAA1-IL-1b axis. Journal of Experimental & Clinical Cancer Research, 2025,44(1):1–22. (Journal of Experimental & Clinical Cancer Research - http://www.jeccr.com/)
  • NewsRx. Reports Summarize Ovarian Cancer Research from Shanghai First Maternity and Infant Hospital (Tumor cells promote immunosuppression in ovarian cancer via a positive feedback loop with MDSCs through the SAA1-IL-1b axis). OBGYN & Reproduction Week. October 20, 2025; p 743.

Read more